Foundayo Doctor for Weight Loss
FDA-approved oral GLP-1 weight management

Foundayo Doctor for Weight Loss

Foundayo contains orforglipron, an oral GLP-1 receptor agonist approved in 2026 for chronic weight management in eligible adults. W8MD physicians can compare this once-daily tablet with Wegovy, Zepbound and non-GLP-1 options.

NYC: 718-946-5500Philadelphia: 215-676-2334

Foundayo orforglipron oral weight loss medication consultation

Current FDA status: Foundayo is FDA approved in combination with reduced-calorie nutrition and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight plus at least one weight-related condition.

What is Foundayo?

Foundayo is the brand name for orforglipron. Unlike peptide GLP-1 tablets that have special fasting instructions, the current Foundayo label permits once-daily administration with or without food. Tablets should be swallowed whole and should not be broken, crushed or chewed.

Treatment begins at the labeled starting dose and escalates no sooner than the intervals described in the prescribing information. The starting dose is intended for initiation rather than maintenance. Patients should not accelerate escalation or take more than one tablet per day.

Foundayo compared with injectable options

Feature Foundayo Wegovy injection Zepbound
Ingredient Orforglipron Semaglutide Tirzepatide
Form Once-daily tablet Once-weekly injection Once-weekly injection
Mechanism Oral small-molecule GLP-1 agonist GLP-1 receptor agonist Dual GIP/GLP-1 receptor agonist
Selection Medical history, expected benefit, administration preference, adverse effects, coverage, availability and cost

Who may be evaluated?

Patients seeking a pill

Some eligible adults prefer oral treatment or want to avoid injections. Preference does not replace contraindication and interaction screening.

People comparing coverage

Visit benefits and pharmacy benefits are separate. Formularies, prior authorization and cost can differ from injectable medicines.

Patients needing comprehensive care

Medication works within nutrition, activity, sleep, follow-up and long-term maintenance planning.

Important safety considerations

  • The label contains a boxed warning concerning the potential risk of thyroid C-cell tumors and contraindicates treatment with a personal or family history of medullary thyroid carcinoma or MEN 2.
  • Do not combine Foundayo with another GLP-1 receptor agonist.
  • Important risks include pancreatitis, severe gastrointestinal reactions, dehydration-related kidney injury, hypoglycemia with certain diabetes medicines, hypersensitivity, diabetic-retinopathy complications, gallbladder disease and aspiration during anesthesia or deep sedation.
  • The label includes product-specific drug-interaction and oral-contraception guidance. Discuss every prescription, supplement and pregnancy plan.
  • Weight-loss medication should not be used during pregnancy.

How W8MD can help

W8MD evaluates weight history, conditions, medications, sleep, nutrition, previous treatments, pregnancy plans, insurance, budget and preferences. The safest reasonable option may be Foundayo, another approved GLP-1/GIP treatment, a traditional prescription or a medication-free medical program.

Prescription hub · Medication guide · GLP-1 comparison · Side-effect management · Insurance guide · W8MD.com

Frequently asked questions

Is Foundayo the same as oral semaglutide?

No. Foundayo contains orforglipron. Wegovy tablets and Rybelsus contain semaglutide and have different indications and administration instructions.

Does Foundayo need to be taken on an empty stomach?

The current label permits taking it with or without food. Follow the complete prescription instructions.

Can Foundayo be taken with Wegovy or Zepbound?

Concomitant use with another GLP-1 receptor agonist is not recommended. Do not combine weight-loss products independently.

Will insurance cover it?

Coverage depends on the specific pharmacy benefit, formulary and prior-authorization rules. No office can guarantee approval.

Authoritative source

Current FDA Foundayo prescribing information · FDA approval announcement · WikiMD orforglipron article

Request an appointment

For faster assistance call Brooklyn at 718-946-5500 or Philadelphia at 215-676-2334. Do not send personal medical information or urgent concerns through this general form.


    Call W8MD for appointments and questions

    Brooklyn / New York City Office
    718-946-5500

    Northeast Philadelphia Office
    215-676-2334


    Calling the appropriate W8MD office is the fastest way to request an
    appointment or ask about services, availability, pricing or insurance.
    This form is only for non-urgent callback requests.

    Privacy notice: Please provide only the contact information
    requested below. Do not submit symptoms, diagnoses, medical history,
    medication information, photographs, insurance identification numbers,
    Social Security numbers, payment information or other sensitive information.


    A telephone number is required so the selected W8MD office can respond and
    assist with scheduling.


    Brooklyn / NYC:

    2632 East 21st Street, Suite L3

    Brooklyn, NY 11235

    Call 718-946-5500


    Northeast Philadelphia:

    1718 Welsh Road, 2nd Floor, Suite C

    Philadelphia, PA 19115

    Call 215-676-2334

    Anti-spam verification

    Please answer the randomly selected question:


    Fields marked with * are required.


    Do not use this form for urgent medical concerns.
    Call 911 or seek emergency medical care in an emergency.

    Medical disclaimer: Educational information only; not medical advice or a guarantee of prescribing, coverage, availability or results. A medical evaluation is required. Call 911 for an emergency.

    Physician-supervised care since 2011

    More Than a Weight-Loss Prescription

    Established in 2011, W8MD provides a comprehensive approach to weight management by connecting prescription treatment with nutrition, metabolic health, sleep medicine, long-term maintenance and selected medical-aesthetic services. Each plan begins with an individualized medical evaluation.

    Medical Weight Loss

    Compare physician-supervised treatment plans based on medical history, previous weight-loss attempts, goals, medication safety, insurance coverage, preferences and cost.

    Explore medical weight loss

    Affordable GLP-1 Options

    W8MD evaluates eligible patients for semaglutide, tirzepatide and other appropriate GLP-1 or related treatments, with monitoring for response, tolerability and long-term maintenance.

    Review GLP-1 injections

    Prescription Diet Pills

    Traditional options may include phentermine, Qsymia, Contrave, orlistat, diethylpropion, phendimetrazine or other individualized strategies when medically appropriate.

    Compare weight-loss medications

    Sleep, Nutrition & MedSpa

    W8MD connects weight management with sleep-apnea evaluation, home sleep testing, nutrition support, IV or IM wellness options and selected MedSpa services.

    Sleep medicine  ·  Nutrition  ·  MedSpa

    Why Patients Choose W8MD

    • Experienced physician-supervised care
    • GLP-1 injections and oral medication options
    • Traditional prescription weight-loss medicines
    • Insurance-friendly visits and self-pay pathways
    • Nutrition, sleep and metabolic-health support
    • Strategies for plateaus and long-term maintenance

    Medical evaluation is required before prescription treatment. Eligibility, medication choice, availability, insurance coverage, pricing and results vary. This information is educational and does not replace individualized medical advice. Individual results are not guaranteed.

    Start typing and press Enter to search

    Shopping Cart